HARROW INC (HROW) Fundamental Analysis & Valuation

NASDAQ:HROW • US4158581094

Current stock price

35.13 USD
-0.18 (-0.51%)
At close:
35.13 USD
0 (0%)
After Hours:

This HROW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. HROW Profitability Analysis

1.1 Basic Checks

  • HROW had positive earnings in the past year.
  • In the past year HROW had a positive cash flow from operations.
  • In the past 5 years HROW always reported negative net income.
  • HROW had a positive operating cash flow in 4 of the past 5 years.
HROW Yearly Net Income VS EBIT VS OCF VS FCFHROW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.29%, HROW is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -9.80%, HROW is in the better half of the industry, outperforming 74.48% of the companies in the same industry.
  • HROW has a Return On Invested Capital of 7.95%. This is amongst the best in the industry. HROW outperforms 86.98% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HROW is significantly below the industry average of 13.06%.
  • The last Return On Invested Capital (7.95%) for HROW is above the 3 year average (3.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.29%
ROE -9.8%
ROIC 7.95%
ROA(3y)-4.53%
ROA(5y)-8.27%
ROE(3y)-23.13%
ROE(5y)-56.8%
ROIC(3y)3.53%
ROIC(5y)2.67%
HROW Yearly ROA, ROE, ROICHROW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • With an excellent Operating Margin value of 11.21%, HROW belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
  • In the last couple of years the Operating Margin of HROW has grown nicely.
  • HROW's Gross Margin of 75.05% is amongst the best of the industry. HROW outperforms 81.77% of its industry peers.
  • HROW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.21%
PM (TTM) N/A
GM 75.05%
OM growth 3Y72.93%
OM growth 5Y48.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y1.28%
HROW Yearly Profit, Operating, Gross MarginsHROW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HROW Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HROW is destroying value.
  • HROW has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, HROW has more shares outstanding
  • HROW has a worse debt/assets ratio than last year.
HROW Yearly Shares OutstandingHROW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
HROW Yearly Total Debt VS Total AssetsHROW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • HROW has an Altman-Z score of 2.99. This indicates that HROW is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of HROW (2.99) is better than 67.19% of its industry peers.
  • The Debt to FCF ratio of HROW is 5.69, which is a neutral value as it means it would take HROW, 5.69 years of fcf income to pay off all of its debts.
  • HROW has a better Debt to FCF ratio (5.69) than 82.81% of its industry peers.
  • A Debt/Equity ratio of 4.64 is on the high side and indicates that HROW has dependencies on debt financing.
  • HROW's Debt to Equity ratio of 4.64 is on the low side compared to the rest of the industry. HROW is outperformed by 82.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.64
Debt/FCF 5.69
Altman-Z 2.99
ROIC/WACC0.84
WACC9.41%
HROW Yearly LT Debt VS Equity VS FCFHROW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that HROW has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.20, HROW perfoms like the industry average, outperforming 42.71% of the companies in the same industry.
  • HROW has a Quick Ratio of 2.06. This indicates that HROW is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.06, HROW perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.06
HROW Yearly Current Assets VS Current LiabilitesHROW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. HROW Growth Analysis

3.1 Past

  • HROW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 104.55%, which is quite impressive.
  • The Revenue has grown by 36.41% in the past year. This is a very strong growth!
  • The Revenue has been growing by 40.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)104.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.17%
Revenue 1Y (TTM)36.41%
Revenue growth 3Y45.39%
Revenue growth 5Y40.99%
Sales Q2Q%33.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 216.53% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 33.73% on average over the next years. This is a very strong growth
EPS Next Y6823.25%
EPS Next 2Y1111.41%
EPS Next 3Y532.86%
EPS Next 5Y216.53%
Revenue Next Year29.51%
Revenue Next 2Y38.93%
Revenue Next 3Y38.33%
Revenue Next 5Y33.73%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HROW Yearly Revenue VS EstimatesHROW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
HROW Yearly EPS VS EstimatesHROW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. HROW Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 1756.50 indicates a quite expensive valuation of HROW.
  • HROW's Price/Earnings ratio is a bit cheaper when compared to the industry. HROW is cheaper than 76.56% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.21. HROW is valued rather expensively when compared to this.
  • HROW is valuated quite expensively with a Price/Forward Earnings ratio of 25.37.
  • 75.00% of the companies in the same industry are more expensive than HROW, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, HROW is valued at the same level.
Industry RankSector Rank
PE 1756.5
Fwd PE 25.37
HROW Price Earnings VS Forward Price EarningsHROW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 500 1K 1.5K

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HROW indicates a somewhat cheap valuation: HROW is cheaper than 77.08% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, HROW is valued cheaper than 82.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.59
EV/EBITDA 29.91
HROW Per share dataHROW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • HROW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HROW has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as HROW's earnings are expected to grow with 532.86% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y1111.41%
EPS Next 3Y532.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HROW Dividend Analysis

5.1 Amount

  • No dividends for HROW!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HROW Fundamentals: All Metrics, Ratios and Statistics

HARROW INC

NASDAQ:HROW (4/6/2026, 8:00:02 PM)

After market: 35.13 0 (0%)

35.13

-0.18 (-0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-02
Earnings (Next)05-06
Inst Owners60.86%
Inst Owner Change0.06%
Ins Owners14.8%
Ins Owner Change2.47%
Market Cap1.31B
Revenue(TTM)272.30M
Net Income(TTM)-5.14M
Analysts85.71
Price Target69.36 (97.44%)
Short Float %20.1%
Short Ratio8.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.46%
Min EPS beat(2)-54.8%
Max EPS beat(2)-18.12%
EPS beat(4)1
Avg EPS beat(4)153.68%
Min EPS beat(4)-970.3%
Max EPS beat(4)1657.94%
EPS beat(8)3
Avg EPS beat(8)79.23%
EPS beat(12)3
Avg EPS beat(12)-68.6%
EPS beat(16)5
Avg EPS beat(16)-818.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-1.25%
Revenue beat(4)0
Avg Revenue beat(4)-7.25%
Min Revenue beat(4)-17.73%
Max Revenue beat(4)-1.25%
Revenue beat(8)2
Avg Revenue beat(8)-3.16%
Revenue beat(12)4
Avg Revenue beat(12)-2.86%
Revenue beat(16)6
Avg Revenue beat(16)-1.85%
PT rev (1m)-3.84%
PT rev (3m)-3.84%
EPS NQ rev (1m)-580.5%
EPS NQ rev (3m)-363.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.09%
Revenue NQ rev (1m)-23.19%
Revenue NQ rev (3m)-22.43%
Revenue NY rev (1m)-8.91%
Revenue NY rev (3m)-9.77%
Valuation
Industry RankSector Rank
PE 1756.5
Fwd PE 25.37
P/S 4.8
P/FCF 30.59
P/OCF 29.82
P/B 24.94
P/tB N/A
EV/EBITDA 29.91
EPS(TTM)0.02
EY0.06%
EPS(NY)1.38
Fwd EY3.94%
FCF(TTM)1.15
FCFY3.27%
OCF(TTM)1.18
OCFY3.35%
SpS7.31
BVpS1.41
TBVpS-3.34
PEG (NY)0.26
PEG (5Y)N/A
Graham Number0.8
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -9.8%
ROCE 10.07%
ROIC 7.95%
ROICexc 10.47%
ROICexgc 45.01%
OM 11.21%
PM (TTM) N/A
GM 75.05%
FCFM 15.7%
ROA(3y)-4.53%
ROA(5y)-8.27%
ROE(3y)-23.13%
ROE(5y)-56.8%
ROIC(3y)3.53%
ROIC(5y)2.67%
ROICexc(3y)4.56%
ROICexc(5y)4.34%
ROICexgc(3y)19.98%
ROICexgc(5y)16.24%
ROCE(3y)4.47%
ROCE(5y)3.38%
ROICexgc growth 3Y47.43%
ROICexgc growth 5Y53.72%
ROICexc growth 3Y36.57%
ROICexc growth 5Y20.03%
OM growth 3Y72.93%
OM growth 5Y48.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y1.28%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 4.64
Debt/FCF 5.69
Debt/EBITDA 4.92
Cap/Depr 5.83%
Cap/Sales 0.4%
Interest Coverage 1.63
Cash Conversion 88.76%
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.06
Altman-Z 2.99
F-Score6
WACC9.41%
ROIC/WACC0.84
Cap/Depr(3y)534.18%
Cap/Depr(5y)356.54%
Cap/Sales(3y)45.63%
Cap/Sales(5y)28.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.17%
EPS Next Y6823.25%
EPS Next 2Y1111.41%
EPS Next 3Y532.86%
EPS Next 5Y216.53%
Revenue 1Y (TTM)36.41%
Revenue growth 3Y45.39%
Revenue growth 5Y40.99%
Sales Q2Q%33.31%
Revenue Next Year29.51%
Revenue Next 2Y38.93%
Revenue Next 3Y38.33%
Revenue Next 5Y33.73%
EBIT growth 1Y232.7%
EBIT growth 3Y151.42%
EBIT growth 5Y109.84%
EBIT Next Year259.42%
EBIT Next 3Y93.43%
EBIT Next 5Y57.48%
FCF growth 1Y170.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y297.57%
OCF growth 3Y194.92%
OCF growth 5YN/A

HARROW INC / HROW Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HARROW INC?

ChartMill assigns a fundamental rating of 6 / 10 to HROW.


What is the valuation status of HARROW INC (HROW) stock?

ChartMill assigns a valuation rating of 6 / 10 to HARROW INC (HROW). This can be considered as Fairly Valued.


What is the profitability of HROW stock?

HARROW INC (HROW) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for HROW stock?

The Earnings per Share (EPS) of HARROW INC (HROW) is expected to grow by 6823.25% in the next year.


Is the dividend of HARROW INC sustainable?

The dividend rating of HARROW INC (HROW) is 0 / 10 and the dividend payout ratio is 0%.